Emerging evidence identifies the CD47–TSP1 axis as a pivotal upstream regulator of chronic inflammation, defective efferocytosis, and extracellular matrix degradation—processes central to aneurysm pathogenesis. This evidence concerns the gene CD47 and aneurysm.